New injection trial aims to protect kidneys from immune attack
NCT ID NCT06983028
Summary
This study is testing an investigational drug called atacicept in people with several autoimmune kidney diseases. Participants will receive weekly injections to see if the treatment is safe and if it can reduce harmful protein in the urine and help preserve kidney function. The goal is to better control these chronic conditions that currently have limited treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHROTIC SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vera Therapeutics
RECRUITINGBrisbane, California, 94005, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.